Belimumab - an anti-BLyS human monoclonal antibody for rheumatoid arthritis

Xingzhong Jin, Changhai Ding

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)


These results suggest that the clinical efficacy of belimumab for RA needs to be further investigated in future clinical trials. Careful patient selection may be necessary for belimumab to achieve optimal clinical outcomes in RA.
Original languageEnglish
Pages (from-to)315 - 322
Number of pages8
JournalExpert Opinion on Biological Therapy
Issue number2
Publication statusPublished - 2013

Cite this